Dinesh V. Ph D. Patel, President and CEO at Protagonist Therapeutics, Inc (PTGX), sold 54,273 shares at $84.59 ($4.1M) on 2026-01-23, disclosed to the SEC on 2026-01-27.
Seasonal sale ($4.1M) by President and CEO — this insider has traded PTGX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 6,000 | $0 | 0.0% |
| 2 | $84.59 | 19,315 | $1.6M | 40.2% |
| 3 | $84.00 | 10,685 | $898K | 22.1% |
| 4 | $84.05 | 14,205 | $1.2M | 29.4% |
| 5 | $83.19 | 4,068 | $338K | 8.3% |
| Total | $74.88 avg | 54,273 |
| $4.1M |
| 100% |
| Filing → |
| PTGX | SELL | 2026-03-25 | $5.5M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $2.8M | — | Filing → |
| PTGX | SELL | 2025-07-28 | $1.1M | — | Filing → |